RT Journal Article
SR Electronic
T1 A Process-Mining Model to Detect Adverse Postoperative Blood Transfusions
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.09.21.22280177
DO 10.1101/2022.09.21.22280177
A1 Ahmet Murat Sumer
A1 Cemil Ceylan
YR 2022
UL http://medrxiv.org/content/early/2022/09/23/2022.09.21.22280177.abstract
AB Importance Errors that threaten patient safety can cause patient harm, death, and rising health care costs. Manual process to expose adverse events (AE) increase time spend to detect them and increase costs of detection.Objective This study aims to make it easier and faster to expose AEs related with postoperative blood usages by process mining.Design These errors can be reported voluntarily by healthcare givers or exposed by Global Trigger Tool (GTT) determined by the Institute for Healthcare Improvement (IHI). With process mining ‘Transfusion of Blood or Use of Blood Products’ (C1) cases were exposed in a data set. Actual life process was discovered and GTT C1 was searched as a process pattern in the discovered process. Instead of reviewing all cases manually, only detected cases were reviewed by patient safety subject matter experts.Setting and Participants Anadolu Medical Center, Turkey was selected as the reference site for this quality improvement study. The data set includes 42,086 records, 2,870 cases and 20 activities for the period between October and December 2018.Main Outcomes and Measures With the new process mining model, data was reduced to 2,704 records, 57 cases and 16 activities. 57 cases detected by the model were analyzed by the expert group and 10 of them are defined as AEs. Rate of C1 AEs per medical record is 1.0%. The rate of C1 AEs per medical record was between 1.3% and 8.3% in other research papers.Conclusions and Relevance Instead of running the classic GTT model manually, only detected 57 patient files were analyzed. The new model 95% decreases time of experts who will review medical records to expose AEs.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study did not receive any fundingAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Medical Ethics Committee of Anadolu Medical Center (Anadolu Saglik Merkezi) / Turkey gave ethical approval for this workI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors